Aurora Cannabis (TSE:ACB) Hits New 12-Month Low at $0.85

Aurora Cannabis Inc. (TSE:ACBGet Rating)’s stock price reached a new 52-week low on Friday . The company traded as low as C$0.85 and last traded at C$0.86, with a volume of 281511 shares traded. The stock had previously closed at C$0.89.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. CIBC dropped their target price on Aurora Cannabis from C$2.25 to C$1.75 and set a “neutral” rating for the company in a research report on Monday, February 13th. Jefferies Financial Group decreased their price target on Aurora Cannabis from C$1.80 to C$1.31 in a research note on Tuesday, February 28th. Canaccord Genuity Group decreased their price target on Aurora Cannabis from C$2.00 to C$1.50 in a research note on Friday, February 10th. Finally, Stifel Nicolaus decreased their price target on Aurora Cannabis from C$1.45 to C$1.20 in a research note on Monday, February 13th. Seven investment analysts have rated the stock with a hold rating, According to, Aurora Cannabis currently has a consensus rating of “Hold” and a consensus price target of C$2.31.

Aurora Cannabis Stock Down 2.2 %

The company has a debt-to-equity ratio of 38.00, a current ratio of 4.08 and a quick ratio of 2.48. The stock has a market capitalization of C$296.66 million, a PE ratio of -0.11 and a beta of 3.02. The company has a 50 day moving average price of C$1.07 and a 200-day moving average price of C$1.37.

Aurora Cannabis (TSE:ACBGet Rating) last posted its earnings results on Thursday, February 9th. The company reported C($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.09) by C($0.10). The firm had revenue of C$69.17 million during the quarter, compared to analysts’ expectations of C$57.00 million. As a group, analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

(Get Rating)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market.

Further Reading

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with’s FREE daily email newsletter.

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *